In the BioHarmony Drug Report Database
Azathioprine
Imuran, Jayempi (azathioprine) is a small molecule pharmaceutical. Azathioprine was first approved as Imuran on 1982-01-01. It is used to treat crohn disease, multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus, and thrombocytopenic purpura idiopathic amongst others in the USA. It has been approved in Europe to treat graft rejection. It is known to target C5a anaphylatoxin chemotactic receptor 1.
Trade Name
|
Jayempi |
|---|---|
Common Name
|
azathioprine |
ChEMBL ID
|
CHEMBL1542 |
Indication
|
crohn disease, graft rejection, multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus, thrombocytopenic purpura idiopathic, ulcerative colitis |
Drug Class
|
Image (chem structure or protein)